Partner Activities: Letters

On behalf of the patients we represent, lowering drug prices should be a priority, but H.R. 3 is not the solution. H.R. 3 will limit innovation and restrict access to life-saving medications.

The 6 Protected Classes promote the health of the most vulnerable. See how state partners voiced concerns to recent threats.